Tezepelumab Benefits Asthma Patients Year-Round

(MedPage Today) -- PHOENIX -- Patients with severe, uncontrolled asthma experienced greater relief throughout the year when treated with the biologic tezepelumab (Tezspire) versus placebo, according to findings from the phase III NAVIGATOR study...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news